Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from cernumbiosciences.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
In our analysis, lot "201-139-35496" appears on 21 different peptides at Cernum Biosciences: aod-9604, bpc-157, bpc-157-tb-500, cjc-1295, ghk-cu, glow-blend, igf-1-lr3, ipamorelin, kisspeptin-10, klow-blend, melanotan-i, melanotan-ii, mots-c, pt-141, retatrutide, selank, semaglutide, sermorelin, tb-500, tesamorelin, tesamorelin-ipamorelin. A lot number normally identifies a single manufacturing batch of one compound, so this pattern can indicate recycled lab data — or a vendor reusing one identifier across a multi-product shipment. Flagged from the COAs available to us; vendors may contest this.
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|
| AOD 9604 | 2 | 99.71% | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| TB-500 | 201-139-35496 | — | 99.70% | — | — | Stats only |
| Melanotan-II | 201-139-35496 | — | 99.60% | — | — | Stats only |
| PT-141 | 201-139-35496 | — | 99.60% | — | — | Stats only |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| — |
| BPC-157 | 5 | 99.69% | — | — | — |
| BPC-157 & TB-500 | 1 | 99.70% | — | — | — |
| CJC-1295 (No DAC) | 2 | 99.28% | — | — | — |
| CJC-1295 + Ipamorelin | 1 | — | — | — | — | — |
| GHK-Cu | 2 | 99.71% | — | — | — |
| Glow 70 | 1 | 99.80% | — | — | — |
| IGF-1 LR3 | 2 | 99.58% | — | — | — |
| Ipamorelin | 2 | 99.49% | — | — | — |
| Kisspeptin-10 | 1 | 99.60% | — | — | — |
| KLOW 80 | 1 | 99.60% | — | — | — |
| Melanotan-1 | 1 | 99.60% | — | — | — |
| Melanotan-II | 2 | 99.67% | — | — | — |
| MOTS-C | 2 | 99.66% | — | — | — |
| NAD+ | 2 | — | — | — | — | — |
| PT-141 | 2 | 99.60% | — | — | — |
| Retatrutide | 2 | 99.62% | — | — | — |
| Selank | 2 | 99.53% | — | — | — |
| Semaglutide | 1 | 99.70% | — | — | — |
| Sermorelin | 2 | 99.27% | — | — | — |
| TB-500 | 2 | 99.38% | — | — | — |
| Tesamorelin | 2 | 99.69% | — | — | — |
| Tesamorelin & Ipamorelin 8mg | 1 | 99.90% | — | — | — |
| Semaglutide | 201-139-35496 | — | 99.70% | — | — | Stats only |
| Tesamorelin & Ipamorelin 8mg | 201-139-35496 | — | 99.90% | — | — | Stats only |
| KLOW 80 | 201-139-35496 | — | 99.60% | — | — | Stats only |
| Ipamorelin | 201-139-35496 | — | 99.70% | — | — | Stats only |
| MOTS-C | 201-139-35496 | — | 99.50% | — | — | Stats only |
| BPC-157 | 201-139-35496 | — | 99.50% | — | — | Stats only |
| CJC-1295 (No DAC) | 201-139-35496 | — | 99.40% | — | — | Stats only |
| Kisspeptin-10 | 201-139-35496 | — | 99.60% | — | — | Stats only |
| AOD 9604 | 201-139-35496 | — | 99.80% | — | — | Stats only |
| Sermorelin | 201-139-35496 | — | 99.40% | — | — | Stats only |
| Glow 70 | 201-139-35496 | — | 99.80% | — | — | Stats only |
| IGF-1 LR3 | 201-139-35496 | — | 99.70% | — | — | Stats only |
| BPC-157 & TB-500 | 201-139-35496 | — | 99.70% | — | — | Stats only |
| GHK-Cu | 201-139-35496 | — | 99.80% | — | — | Stats only |
| NAD+ | — | — | — | — | — | Stats only |
| Retatrutide | 201-139-35496 | — | 99.70% | — | — | Stats only |
| Selank | 201-139-35496 | — | 99.50% | — | — | Stats only |
| Melanotan-1 | 201-139-35496 | — | 99.60% | — | — | Stats only |
| Tesamorelin | 201-139-35496 | — | 99.60% | — | — | Stats only |
| — | — | — | — | — | — | View |
| — | — | — | — | — | — | View |
| Retatrutide | — | Janoshik Analytical | 99.53% | — | 2025-11-03 | View |
| BPC-157 | — | Janoshik Analytical | — | — | 2025-11-03 | View |
| IGF-1 LR3 | — | Janoshik Analytical | 99.45% | — | 2025-11-03 | View |
| NAD+ | — | Janoshik Analytical | — | — | 2025-11-03 | View |
| GHK-Cu | — | Janoshik Analytical | 99.62% | — | 2025-11-03 | View |
| BPC-157 | — | Janoshik Analytical | — | — | 2025-11-03 | View |
| Melanotan 2 | — | Janoshik Analytical | 99.75% | — | 2025-11-03 | View |
| CJC-1295 + Ipamorelin | — | Janoshik Analytical | — | — | 2025-11-03 | View |
| GHK-CU / TB-500 / BPC-157 | — | Janoshik Analytical | — | — | 2025-11-03 | View |
| CJC-1295 (mod GRF 1-29) | — | Janoshik Analytical | 99.15% | — | 2025-10-31 | View |
| Tesamorelin | — | Janoshik Analytical | 99.78% | — | 2025-10-31 | View |
| MOTS-C | — | Janoshik Analytical | 99.82% | — | 2025-10-31 | View |
| BPC-157 | — | Janoshik Analytical | 99.88% | — | 2025-10-31 | View |
| AOD-9604 | — | Janoshik Analytical | 99.63% | — | 2025-05-15 | View |
| Ipamorelin | — | Janoshik Analytical | 99.29% | — | 2025-05-14 | View |
| PT-141 | — | Janoshik Analytical | 99.60% | — | 2025-05-14 | View |
| TB-500 | — | Janoshik Analytical | 99.06% | — | 2025-05-14 | View |
| Selank | — | Janoshik Analytical | 99.55% | — | 2025-05-14 | View |
| Sermorelin Acetate | — | Janoshik Analytical | 99.13% | — | 2025-05-14 | View |
Disclosed Labs